This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Advances in Antiviral Treatment

Steven I. Marlowe, MD

Arch Dermatol. 1985;121(4):467-470.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is estimated that 5 to 20 million persons in the United States have genital herpes, with 260,000 to 500,000 new cases occurring each year. The need for effective agents for treatment, prevention, and cure is obvious, but the psychosocial morbidity associated with genital herpes infections is less well appreciated. A new era in the treatment of genital herpes infections has begun with the advent of effective antiviral chemotherapy. Physicians have been frustrated by a lack of specific therapy for this trouble some and sometimes devastating skin disease for centuries. In his excellent review and clinical classification of herpes skin infections, Ferdinand Hebra¹ in 1866 took the following position in response to the toxic treatments popular in his day: "the fact... herpes terminates within a tolerably short time is sufficient to show that any special treatment of this disease is unnecessary." He goes on to say, "Experience, then, teaches that an expectant treatment is . . . [Full Text PDF of this Article]

Author Affiliations
Boston

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?